...
首页> 外文期刊>Pharmaceutical Biology >Antidiabetic potential of alpha-amylase inhibitor from the seeds of Macrotyloma uniflorum in streptozotocin-nicotinamide-induced diabetic mice.
【24h】

Antidiabetic potential of alpha-amylase inhibitor from the seeds of Macrotyloma uniflorum in streptozotocin-nicotinamide-induced diabetic mice.

机译:单链巨杆菌瘤种子中α-淀粉酶抑制剂在链脲佐菌素-烟酰胺诱导的糖尿病小鼠中的抗糖尿病潜力。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

CONTEXT: Macrotyloma uniflorum (Lam.) Verdc. (Leguminosae) seeds, known as the poor man's pulse crop in India, have been used as a food and also used in the traditional method for treatment of kidney stones, diabetes, obesity, etc. OBJECTIVE: To investigate the antidiabetic effect of alpha-amylase inhibitor isolated from the seeds of Macrotyloma uniflorum seeds in streptozotocin-nicotinamide induced diabetic mice. MATERIALS AND METHOD: alpha-Amylase inhibitor was purified using a carboxymethyl cellulose (CMC) column. Kinetic studies were done using mouse pancreatic and human salivary alpha-amylase. Its antidiabetic effect was studied in streptozotocin-nicotinamide-induced diabetic mice. Biochemical parameters such as serum total cholesterol, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were determined. Histopathological investigation was performed on the pancreas, kidney, and liver tissue samples. RESULTS: Macrotyloma uniflorum alpha-amylase inhibitor (MUAI) inhibited both the mouse pancreatic and human salivary alpha-amylase in a non-competitive manner with K(i) values of 11 and 8.8 microM and IC(50) value of 30 and 12.5 microg/mL, respectively. It decreased the serum glucose level in the treated diabetic mice. Histological findings suggested minimum pathological changes in the treated diabetic mice as compared to the diabetic control. DISCUSSION AND CONCLUSION: The results suggest that MUAI has an antihyperglycemic activity and therefore can be used in the dietary treatment of non-insulin dependent diabetes mellitus.
机译:语境:巨大花单胞菌(Lam。)Verdc。 (豆科)种子,在印度被称为穷人的豆类作物,已被用作食品,也被用于治疗肾结石,糖尿病,肥胖症等的传统方法。目的:研究α-抗糖尿病药的抗糖尿病作用链脲佐菌素-烟酰胺诱导的糖尿病小鼠中,从巨圆种子种子中分离的淀粉酶抑制剂。材料与方法:使用羧甲基纤维素(CMC)柱纯化α-淀粉酶抑制剂。使用小鼠胰腺和人类唾液α-淀粉酶进行了动力学研究。在链脲佐菌素-烟酰胺诱导的糖尿病小鼠中研究了其抗糖尿病作用。确定了生化参数,例如血清总胆固醇,天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)的水平。对胰腺,肾脏和肝脏组织样本进行了组织病理学研究。结果:巨细胞瘤单花α-淀粉酶抑制剂(MUAI)以非竞争性方式抑制小鼠胰腺和人类唾液α-淀粉酶,K(i)值为11和8.8 microM,IC(50)值为30和12.5 microg。 / mL。它降低了治疗的糖尿病小鼠的血清葡萄糖水平。组织学发现表明,与糖尿病对照相比,治疗的糖尿病小鼠的病理改变最小。讨论与结论:结果表明MUAI具有降血糖活性,因此可用于非胰岛素依赖型糖尿病的饮食治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号